Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Leukemia Research|March 19, 2013
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)Cecile Bally, Sylvain Thépot, Bruno Quesnel, et al.
Haematologica|February 17, 2022
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphomaLouise Bouard, Benoit Tessoulin, Catherine Thieblemont, et al.
Annals of Hematology|July 30, 2025
Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS)Anne Quinquenel, Stéphane Leprêtre, Marie Sarah Dilhuydy, et al.
Experimental Hematology & Oncology|April 16, 2016
Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignanciesClémentine Gamonet, Elodie Bole-Richard, Aurélia Delherme, et al.
Annals of Hematology|August 29, 2019
Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo<sup>2</sup>study)Thomas Chalopin, Nicolas Vallet, Flavie Arbion, et al.
Blood|September 19, 2008
Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 studyGilles Salles, Nicolas Mounier, Sophie de Guibert, et al.
Annals of Hematology|March 5, 2024
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE studyCaroline Dartigeas, Anne Quinquenel, Loïc Ysebaert, et al.
Blood|July 29, 2010
Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)Sylvain Thepot, Raphael Itzykson, Valerie Seegers, et al.
British Journal of Haematology|April 24, 2024
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)Florence Nguyen-Khac, Marine Baron, Romain Guièze, et al.
Blood|February 14, 2018
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinibDavid Ghez, Anne Calleja, Caroline Protin, et al.
Pageof 5